Company / Financials
Teladoc Health, Inc. Financials
FY2013-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$2.5B
FY2025 · -1.5% YoY
Net Income
-$200.3M
FY2025 · +80.0% YoY
Profit Margin
-7.9%
FY2025 · net income / revenue
ROE
-14.5%
FY2025 · return on equity
Total Assets
$2.9B
FY2025
Total Debt
-
FY2025
Equity
$1.4B
FY2025
ROA
-7.0%
FY2025 · return on assets
Statement paths
Financial highlights
Key Data Points
- Altman Z-Score -3.70 (distress zone, below 1.8 threshold)
- Negative profit margin: -8.8%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Metric history
Revenue HistoryTotal revenue from operations$2.5B-1.5% YoYNet Income HistoryProfit after all expenses and taxes-$200.3M+80.0% YoYGross Profit HistoryRevenue minus cost of goods sold-Cost of Revenue HistoryDirect costs of producing goods and services sold-Operating Income HistoryProfit from core business operations before interest and taxes-$263.0M+74.2% YoYSG&A Expense HistorySelling, general, and administrative expenses$431.9M-0.8% YoYR&D Expense HistoryResearch and development spending$277.9M-9.6% YoYInterest Expense HistoryCost of borrowing and debt obligations-Income Tax HistoryTotal income tax expense-$35.2M-563.8% YoYEPS (Basic) HistoryBasic earnings per share-$1.34+98.4% YoY